Issue 6/2014
Content (8 Articles)
Acknowledgement to Referees
Novel Therapeutic Targets in the Management of Atrial Fibrillation
Abhishek Maan, Moussa Mansour, David D. McManus, Vickas V. Patel, Alan Cheng, Jeremy N. Ruskin, E. Kevin Heist
Thiazide-Like/Calcium Channel Blocker Agents: A Major Combination for Hypertension Management
M. E. Safar, J. Blacher
The Cardioprotection of the Insulin-Mediated PI3K/Akt/mTOR Signaling Pathway
Hong Yao, Xiangyang Han, Xiuzhen Han
Patterns in the Use of Low-Dose Acetylsalicylic Acid and Other Therapies Following Upper Gastrointestinal Bleeding
María E. Sáez, Antonio González-Pérez, Saga Johansson, Péter Nagy, Luis A. García Rodríguez
Cost Effectiveness of New Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in Two Different European Healthcare Settings
Talitha I. Verhoef, William K. Redekop, Fazila Hasrat, Anthonius de Boer, Anke Hilse Maitland-van der Zee
Epoprostenol (Veletri®, Caripul®): A Review of Its Use in Patients with Pulmonary Arterial Hypertension
Sarah L. Greig, Lesley J. Scott, Greg L. Plosker
Icosapent Ethyl: A Review of Its Use in Severe Hypertriglyceridemia
Esther S. Kim, Paul L. McCormack